Notably, semaglutide significantly increased the likelihood of achieving a 2-level reduction in WHO risk drinking level, a clinical trial endpoint recently qualified by the US Food and Drug Administration (FDA), with a number-needed-to-treat of 4.3 suggesting potentially greater efficacy relative to existing alcohol use disorder medications. (!) They see practical applications: GLP-1 therapies could prove effective for reducing drinking levels in mild or prodromal alcohol use disorder, perhaps offering a treatment that can be delivered in primary care. Christian S
If your goal is large rapid weight loss these supplements are unlikely to be the sole answer
Exenatide once weekly plus Dapagliflozin once daily versus exenatide or Dapagliflozin alone in patients with type 2 diabetes inadequately controlled with Metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
Combining treatments should be under the guidance of a healthcare professional
Taking oral semaglutide Our oral semaglutide leverages the weight loss power of GLP-1 in a convenient oral drop format, so losing weight doesnt have to be hard
